hypoglycemia on semaglutide as a helpful choice in challenging clinical scenarios a Which of the following GLP-1

GLP-1 medications like semaglutide leave your body within days to weeks, but metabolic effects may persist longer

AbstractPurposeAn update of a systematic review and meta-analysis of the risk of arrhythmias and their subtypes in type 2 diabetic patients receiving glucago...

Whilst all GLP-1RAs use has increased, the largest change was seen in patients using tirzepatide and semaglutide ([figure 1B][1])

Notable disparities were observed between the two groups regarding improvements of BMI, SBP, HbA1c, LDL-C, CRP

More than four in five PwO have made a serious attempt at weight loss but less than half of them would have lost 5% of their body weight over three years, and 70% of those that do are expected to regain their losses.11 This illustrates that regardless of the drivers of obesity, PwO are in an established state of pathological energy homeostasis that requires intensification of treatment beyond foundational lifestyle changes, and which often requires the use of anti-obesity medications (AOMs)